Global and Regional Blood Group Typing

Blood Group Typing Comprehensive Study by Application (Hospitals, Clinical Laboratories, Blood Banks, Other End Users), Technique (PCR-Based, Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing, Other Techniques), Test Type (Antibody Screening, HLA Typing, ABO Blood Tests, Cross-Matching Tests, Antigen Typing), End User (Hospitals, Clinical Laboratories, Blood Banks, Other End Users) Players and Region - Global Market Outlook to 2030

Blood Group Typing Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Blood Group Typing Market Scope
The blood group typing service providers are highly fragmented across the globe and some of the major manufacturers have used various strategies including strategic alliances with other brands such as a merger, acquisition, joint venture or partnership as well as new product launches, expansions, and many others to gain a competitive edge in the market. Moreover, the growing number of blood group typing service provides will further generate significant degree competition in a `moderately competitive environment and The increasing demand for blood and blood products, a growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences are the major factors fueling the growth of this market.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
Largest MarketNorth America
UnitValue (USD Billion)
Key Companies ProfiledBio-Rad Laboratories Inc. (United States), Beckman Coulter Inc. (Danaher) (United States), Grifols, S.A. (Spain), Immucor, Inc. (United States), Merck KGaA (Germany), Novacyt Group (France), Quotient Ltd. (United Kingdom), Ortho Clinical Diagnostics (United States), Bag Health Care GmbH (Germany) and Rapid Labs Ltd (United Kingdom)
CAGR9.9%


Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Blood Group Typing market throughout the predicted period.

Bio-Rad Laboratories Inc. (United States), Beckman Coulter Inc. (Danaher) (United States), Grifols, S.A. (Spain), Immucor, Inc. (United States), Merck KGaA (Germany), Novacyt Group (France), Quotient Ltd. (United Kingdom), Ortho Clinical Diagnostics (United States), Bag Health Care GmbH (Germany) and Rapid Labs Ltd (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are AXO Science (France), Agena Bioscience Inc. (United States), Day Medical SA (Switzerland) and DIAGAST (France).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Blood Group Typing market by Type , by Application (Hospitals, Clinical Laboratories, Blood Banks and Other End Users) and Region with country level break-up.

On the basis of geography, the market of Blood Group Typing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In February 2019, a global leader of life science research and clinical diagnostic products ‘Bio-Rad Laboratories, Inc.’ has announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive the United States Food and Drug Administration (FDA) clearance. In the integration of both the systems from Bio-Rad’s system and the kit has enabled the company to provide precise and reproducible monitoring of molecular response to treatment in patients with chronic myeloid leukemia (CML).
In March 2024 Labcorp a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.


Influencing Trend:
Introduction to Technologically Advanced Blood Typing Methods with Minimal Side Effects and Growing Adoption of Blood Transfusion Techniques

Market Growth Drivers:
Rising Utilization of Blood Group Typing in Forensic Science and Growing Applications as well as Need for Blood Typing with respect to Increased Trauma Cases and Road Accidents

Challenges:
Highly Skilled and Experienced Workforce are required for Sensitive Treatments and Mistakes or Errors in Blood Group Typing might cause Numerous Side Effects and even Death

Restraints:
Lack of Awareness and Healthcare Infrastructure in the Underdeveloped Regions and Complex Blood Incompatibility/Compatibility Test

Opportunities:
Growing Awareness about Blood Donations Leading to Increased Blood Donators and Simplified Blood Group Typing Techniques

Key Target Audience
Blood Group Typing Service Providers, Blood Group Typing Service Downstream Buyers, Healthcare Industry Associations, Government Agencies, Research and Development Institutes and Others

Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Clinical Laboratories
  • Blood Banks
  • Other End Users
By Technique
  • PCR-Based
  • Microarray Techniques
  • Assay-Based Techniques
  • Massively Parallel Sequencing
  • Other Techniques

By Test Type
  • Antibody Screening
  • HLA Typing
  • ABO Blood Tests
  • Cross-Matching Tests
  • Antigen Typing

By End User
  • Hospitals
  • Clinical Laboratories
  • Blood Banks
  • Other End Users

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Utilization of Blood Group Typing in Forensic Science
      • 3.2.2. Growing Applications as well as Need for Blood Typing with respect to Increased Trauma Cases and Road Accidents
    • 3.3. Market Challenges
      • 3.3.1. Highly Skilled and Experienced Workforce are required for Sensitive Treatments
      • 3.3.2. Mistakes or Errors in Blood Group Typing might cause Numerous Side Effects and even Death
    • 3.4. Market Trends
      • 3.4.1. Introduction to Technologically Advanced Blood Typing Methods with Minimal Side Effects
      • 3.4.2. Growing Adoption of Blood Transfusion Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Group Typing, by Application, Technique, Test Type, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Blood Group Typing (Value)
      • 5.2.1. Global Blood Group Typing by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Clinical Laboratories
        • 5.2.1.3. Blood Banks
        • 5.2.1.4. Other End Users
      • 5.2.2. Global Blood Group Typing by: Technique (Value)
        • 5.2.2.1. PCR-Based
        • 5.2.2.2. Microarray Techniques
        • 5.2.2.3. Assay-Based Techniques
        • 5.2.2.4. Massively Parallel Sequencing
        • 5.2.2.5. Other Techniques
      • 5.2.3. Global Blood Group Typing by: Test Type (Value)
        • 5.2.3.1. Antibody Screening
        • 5.2.3.2. HLA Typing
        • 5.2.3.3. ABO Blood Tests
        • 5.2.3.4. Cross-Matching Tests
        • 5.2.3.5. Antigen Typing
      • 5.2.4. Global Blood Group Typing by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinical Laboratories
        • 5.2.4.3. Blood Banks
        • 5.2.4.4. Other End Users
      • 5.2.5. Global Blood Group Typing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Blood Group Typing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Beckman Coulter Inc. (Danaher) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Grifols, S.A. (Spain)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Immucor, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck KGaA (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novacyt Group (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Quotient Ltd. (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ortho Clinical Diagnostics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bag Health Care GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Rapid Labs Ltd (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Group Typing Sale, by Application, Technique, Test Type, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Blood Group Typing (Value)
      • 7.2.1. Global Blood Group Typing by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Clinical Laboratories
        • 7.2.1.3. Blood Banks
        • 7.2.1.4. Other End Users
      • 7.2.2. Global Blood Group Typing by: Technique (Value)
        • 7.2.2.1. PCR-Based
        • 7.2.2.2. Microarray Techniques
        • 7.2.2.3. Assay-Based Techniques
        • 7.2.2.4. Massively Parallel Sequencing
        • 7.2.2.5. Other Techniques
      • 7.2.3. Global Blood Group Typing by: Test Type (Value)
        • 7.2.3.1. Antibody Screening
        • 7.2.3.2. HLA Typing
        • 7.2.3.3. ABO Blood Tests
        • 7.2.3.4. Cross-Matching Tests
        • 7.2.3.5. Antigen Typing
      • 7.2.4. Global Blood Group Typing by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinical Laboratories
        • 7.2.4.3. Blood Banks
        • 7.2.4.4. Other End Users
      • 7.2.5. Global Blood Group Typing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Group Typing: by Application(USD Billion)
  • Table 2. Blood Group Typing Hospitals , by Region USD Billion (2018-2023)
  • Table 3. Blood Group Typing Clinical Laboratories , by Region USD Billion (2018-2023)
  • Table 4. Blood Group Typing Blood Banks , by Region USD Billion (2018-2023)
  • Table 5. Blood Group Typing Other End Users , by Region USD Billion (2018-2023)
  • Table 6. Blood Group Typing: by Technique(USD Billion)
  • Table 7. Blood Group Typing PCR-Based , by Region USD Billion (2018-2023)
  • Table 8. Blood Group Typing Microarray Techniques , by Region USD Billion (2018-2023)
  • Table 9. Blood Group Typing Assay-Based Techniques , by Region USD Billion (2018-2023)
  • Table 10. Blood Group Typing Massively Parallel Sequencing , by Region USD Billion (2018-2023)
  • Table 11. Blood Group Typing Other Techniques , by Region USD Billion (2018-2023)
  • Table 12. Blood Group Typing: by Test Type(USD Billion)
  • Table 13. Blood Group Typing Antibody Screening , by Region USD Billion (2018-2023)
  • Table 14. Blood Group Typing HLA Typing , by Region USD Billion (2018-2023)
  • Table 15. Blood Group Typing ABO Blood Tests , by Region USD Billion (2018-2023)
  • Table 16. Blood Group Typing Cross-Matching Tests , by Region USD Billion (2018-2023)
  • Table 17. Blood Group Typing Antigen Typing , by Region USD Billion (2018-2023)
  • Table 18. Blood Group Typing: by End User(USD Billion)
  • Table 19. Blood Group Typing Hospitals , by Region USD Billion (2018-2023)
  • Table 20. Blood Group Typing Clinical Laboratories , by Region USD Billion (2018-2023)
  • Table 21. Blood Group Typing Blood Banks , by Region USD Billion (2018-2023)
  • Table 22. Blood Group Typing Other End Users , by Region USD Billion (2018-2023)
  • Table 23. South America Blood Group Typing, by Country USD Billion (2018-2023)
  • Table 24. South America Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 25. South America Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 26. South America Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 27. South America Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 28. Brazil Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 29. Brazil Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 30. Brazil Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 31. Brazil Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 32. Argentina Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 33. Argentina Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 34. Argentina Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 35. Argentina Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 36. Rest of South America Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 37. Rest of South America Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 38. Rest of South America Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 39. Rest of South America Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 40. Asia Pacific Blood Group Typing, by Country USD Billion (2018-2023)
  • Table 41. Asia Pacific Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 42. Asia Pacific Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 43. Asia Pacific Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 44. Asia Pacific Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 45. China Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 46. China Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 47. China Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 48. China Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 49. Japan Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 50. Japan Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 51. Japan Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 52. Japan Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 53. India Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 54. India Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 55. India Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 56. India Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 57. South Korea Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 58. South Korea Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 59. South Korea Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 60. South Korea Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 61. Taiwan Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 62. Taiwan Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 63. Taiwan Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 64. Taiwan Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 65. Australia Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 66. Australia Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 67. Australia Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 68. Australia Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 69. Rest of Asia-Pacific Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 70. Rest of Asia-Pacific Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 71. Rest of Asia-Pacific Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 72. Rest of Asia-Pacific Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 73. Europe Blood Group Typing, by Country USD Billion (2018-2023)
  • Table 74. Europe Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 75. Europe Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 76. Europe Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 77. Europe Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 78. Germany Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 79. Germany Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 80. Germany Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 81. Germany Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 82. France Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 83. France Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 84. France Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 85. France Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 86. Italy Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 87. Italy Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 88. Italy Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 89. Italy Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 90. United Kingdom Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 91. United Kingdom Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 92. United Kingdom Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 93. United Kingdom Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 94. Netherlands Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 95. Netherlands Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 96. Netherlands Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 97. Netherlands Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 98. Rest of Europe Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 99. Rest of Europe Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 100. Rest of Europe Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 101. Rest of Europe Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 102. MEA Blood Group Typing, by Country USD Billion (2018-2023)
  • Table 103. MEA Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 104. MEA Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 105. MEA Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 106. MEA Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 107. Middle East Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 108. Middle East Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 109. Middle East Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 110. Middle East Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 111. Africa Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 112. Africa Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 113. Africa Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 114. Africa Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 115. North America Blood Group Typing, by Country USD Billion (2018-2023)
  • Table 116. North America Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 117. North America Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 118. North America Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 119. North America Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 120. United States Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 121. United States Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 122. United States Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 123. United States Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 124. Canada Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 125. Canada Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 126. Canada Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 127. Canada Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 128. Mexico Blood Group Typing, by Application USD Billion (2018-2023)
  • Table 129. Mexico Blood Group Typing, by Technique USD Billion (2018-2023)
  • Table 130. Mexico Blood Group Typing, by Test Type USD Billion (2018-2023)
  • Table 131. Mexico Blood Group Typing, by End User USD Billion (2018-2023)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Blood Group Typing: by Application(USD Billion)
  • Table 143. Blood Group Typing Hospitals , by Region USD Billion (2025-2030)
  • Table 144. Blood Group Typing Clinical Laboratories , by Region USD Billion (2025-2030)
  • Table 145. Blood Group Typing Blood Banks , by Region USD Billion (2025-2030)
  • Table 146. Blood Group Typing Other End Users , by Region USD Billion (2025-2030)
  • Table 147. Blood Group Typing: by Technique(USD Billion)
  • Table 148. Blood Group Typing PCR-Based , by Region USD Billion (2025-2030)
  • Table 149. Blood Group Typing Microarray Techniques , by Region USD Billion (2025-2030)
  • Table 150. Blood Group Typing Assay-Based Techniques , by Region USD Billion (2025-2030)
  • Table 151. Blood Group Typing Massively Parallel Sequencing , by Region USD Billion (2025-2030)
  • Table 152. Blood Group Typing Other Techniques , by Region USD Billion (2025-2030)
  • Table 153. Blood Group Typing: by Test Type(USD Billion)
  • Table 154. Blood Group Typing Antibody Screening , by Region USD Billion (2025-2030)
  • Table 155. Blood Group Typing HLA Typing , by Region USD Billion (2025-2030)
  • Table 156. Blood Group Typing ABO Blood Tests , by Region USD Billion (2025-2030)
  • Table 157. Blood Group Typing Cross-Matching Tests , by Region USD Billion (2025-2030)
  • Table 158. Blood Group Typing Antigen Typing , by Region USD Billion (2025-2030)
  • Table 159. Blood Group Typing: by End User(USD Billion)
  • Table 160. Blood Group Typing Hospitals , by Region USD Billion (2025-2030)
  • Table 161. Blood Group Typing Clinical Laboratories , by Region USD Billion (2025-2030)
  • Table 162. Blood Group Typing Blood Banks , by Region USD Billion (2025-2030)
  • Table 163. Blood Group Typing Other End Users , by Region USD Billion (2025-2030)
  • Table 164. South America Blood Group Typing, by Country USD Billion (2025-2030)
  • Table 165. South America Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 166. South America Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 167. South America Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 168. South America Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 169. Brazil Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 170. Brazil Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 171. Brazil Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 172. Brazil Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 173. Argentina Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 174. Argentina Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 175. Argentina Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 176. Argentina Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 177. Rest of South America Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 178. Rest of South America Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 179. Rest of South America Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 180. Rest of South America Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 181. Asia Pacific Blood Group Typing, by Country USD Billion (2025-2030)
  • Table 182. Asia Pacific Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 183. Asia Pacific Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 184. Asia Pacific Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 185. Asia Pacific Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 186. China Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 187. China Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 188. China Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 189. China Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 190. Japan Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 191. Japan Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 192. Japan Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 193. Japan Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 194. India Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 195. India Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 196. India Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 197. India Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 198. South Korea Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 199. South Korea Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 200. South Korea Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 201. South Korea Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 202. Taiwan Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 203. Taiwan Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 204. Taiwan Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 205. Taiwan Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 206. Australia Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 207. Australia Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 208. Australia Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 209. Australia Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 210. Rest of Asia-Pacific Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 211. Rest of Asia-Pacific Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 212. Rest of Asia-Pacific Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 213. Rest of Asia-Pacific Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 214. Europe Blood Group Typing, by Country USD Billion (2025-2030)
  • Table 215. Europe Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 216. Europe Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 217. Europe Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 218. Europe Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 219. Germany Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 220. Germany Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 221. Germany Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 222. Germany Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 223. France Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 224. France Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 225. France Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 226. France Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 227. Italy Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 228. Italy Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 229. Italy Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 230. Italy Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 231. United Kingdom Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 232. United Kingdom Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 233. United Kingdom Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 234. United Kingdom Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 235. Netherlands Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 236. Netherlands Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 237. Netherlands Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 238. Netherlands Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 239. Rest of Europe Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 240. Rest of Europe Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 241. Rest of Europe Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 242. Rest of Europe Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 243. MEA Blood Group Typing, by Country USD Billion (2025-2030)
  • Table 244. MEA Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 245. MEA Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 246. MEA Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 247. MEA Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 248. Middle East Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 249. Middle East Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 250. Middle East Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 251. Middle East Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 252. Africa Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 253. Africa Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 254. Africa Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 255. Africa Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 256. North America Blood Group Typing, by Country USD Billion (2025-2030)
  • Table 257. North America Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 258. North America Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 259. North America Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 260. North America Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 261. United States Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 262. United States Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 263. United States Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 264. United States Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 265. Canada Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 266. Canada Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 267. Canada Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 268. Canada Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 269. Mexico Blood Group Typing, by Application USD Billion (2025-2030)
  • Table 270. Mexico Blood Group Typing, by Technique USD Billion (2025-2030)
  • Table 271. Mexico Blood Group Typing, by Test Type USD Billion (2025-2030)
  • Table 272. Mexico Blood Group Typing, by End User USD Billion (2025-2030)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Group Typing: by Application USD Billion (2018-2023)
  • Figure 5. Global Blood Group Typing: by Technique USD Billion (2018-2023)
  • Figure 6. Global Blood Group Typing: by Test Type USD Billion (2018-2023)
  • Figure 7. Global Blood Group Typing: by End User USD Billion (2018-2023)
  • Figure 8. South America Blood Group Typing Share (%), by Country
  • Figure 9. Asia Pacific Blood Group Typing Share (%), by Country
  • Figure 10. Europe Blood Group Typing Share (%), by Country
  • Figure 11. MEA Blood Group Typing Share (%), by Country
  • Figure 12. North America Blood Group Typing Share (%), by Country
  • Figure 13. Global Blood Group Typing share by Players 2023 (%)
  • Figure 14. Global Blood Group Typing share by Players (Top 3) 2023(%)
  • Figure 15. Global Blood Group Typing share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Beckman Coulter Inc. (Danaher) (United States) Revenue, Net Income and Gross profit
  • Figure 20. Beckman Coulter Inc. (Danaher) (United States) Revenue: by Geography 2023
  • Figure 21. Grifols, S.A. (Spain) Revenue, Net Income and Gross profit
  • Figure 22. Grifols, S.A. (Spain) Revenue: by Geography 2023
  • Figure 23. Immucor, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Immucor, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Merck KGaA (Germany) Revenue: by Geography 2023
  • Figure 27. Novacyt Group (France) Revenue, Net Income and Gross profit
  • Figure 28. Novacyt Group (France) Revenue: by Geography 2023
  • Figure 29. Quotient Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Quotient Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 31. Ortho Clinical Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 32. Ortho Clinical Diagnostics (United States) Revenue: by Geography 2023
  • Figure 33. Bag Health Care GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Bag Health Care GmbH (Germany) Revenue: by Geography 2023
  • Figure 35. Rapid Labs Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Rapid Labs Ltd (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Global Blood Group Typing: by Application USD Billion (2025-2030)
  • Figure 38. Global Blood Group Typing: by Technique USD Billion (2025-2030)
  • Figure 39. Global Blood Group Typing: by Test Type USD Billion (2025-2030)
  • Figure 40. Global Blood Group Typing: by End User USD Billion (2025-2030)
  • Figure 41. South America Blood Group Typing Share (%), by Country
  • Figure 42. Asia Pacific Blood Group Typing Share (%), by Country
  • Figure 43. Europe Blood Group Typing Share (%), by Country
  • Figure 44. MEA Blood Group Typing Share (%), by Country
  • Figure 45. North America Blood Group Typing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio-Rad Laboratories Inc. (United States)
  • Beckman Coulter Inc. (Danaher) (United States)
  • Grifols, S.A. (Spain)
  • Immucor, Inc. (United States)
  • Merck KGaA (Germany)
  • Novacyt Group (France)
  • Quotient Ltd. (United Kingdom)
  • Ortho Clinical Diagnostics (United States)
  • Bag Health Care GmbH (Germany)
  • Rapid Labs Ltd (United Kingdom)
Additional players considered in the study are as follows:
AXO Science (France) , Agena Bioscience Inc. (United States) , Day Medical SA (Switzerland) , DIAGAST (France)
Select User Access Type

Key Highlights of Report


Mar 2024 127 Pages 66 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Regional Blood Group Typing Quantitative research analysis
Global and Regional Blood Group Typing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Blood Group Typing Market are by end use application [Hospitals, Clinical Laboratories, Blood Banks and Other End Users].
The Blood Group Typing Market is gaining popularity and expected to see strong valuation by 2030.
  • Rising Utilization of Blood Group Typing in Forensic Science
  • Growing Applications as well as Need for Blood Typing with respect to Increased Trauma Cases and Road Accidents

Know More About Global and Regional Blood Group Typing Report?

Have a Query? Click Here

Other Related Reports

Cardiovascular Ultrasound Comprehensive Study by Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, Other Echocardiograms), Application (Hospitals, Cardiology ...
$ 3650
Consumer Healthcare Comprehensive Study by Type (OTC Pharmaceuticals, Dietary Supplements, Herbal Products), Distribution Channel (E-Commerce, Retail Stores, Convenience Stores, Pharmacy Stores, Supe...
$ 3350
Foam Dressings Comprehensive Study by Type (Foam Dressings With Adhesive Border, Foam Dressings With Silicone Border), Application (Hospitals, Clinics, Homecare, Other), Pore Size (Small, Medium, Lar...
$ 3500
Pet Health Comprehensive Study by Application (Household, Pet Shop, Veterinary, Others), Product (Pet Food, Pet Accessories, Pet Grooming, Pet Healthcare), Product Distribution Channel (Offline, Onli...
$ 3450
Medical Specialty Bags Comprehensive Study by Type (Ostomy Collection Bags, Intravenous (IV) Fluid bags, Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags, Resuscitation Bags, Urinary Collection ...
$ 3750
Oral Hygiene Comprehensive Study by Type (Brushing, Flossing, Rinsing), Application (Men, Women, Child, Old Age People), Distribution Channel (Consumer Stores, Retail Pharmacies, Online Stores, Denta...
$ 3750